EE261 Cost-Effectiveness of Mixed-Approach Maternal RSVpreF/Infant Nirsevimab Immunization vs. Nirsevimab Alone for Prevention of Respiratory Syncytial Virus in Spain
Abstract
Authors
Alejandra López-Ibáñez de Aldecoa Vanessa López Ahuva Averin Erin Quinn Amy Law